Browse by category

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Dr Elizabeth McDonald, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing brea

A systematic review and meta-analysis has indicated that bariatric surgery may reduce the overall risk of breast cancer in women with obesity, according to researchers from China. However, the studies also revealed a paradoxical finding: Despite the overall reduction in risk, the incidence of stage I breast cancer increased in the surgical group. Nevertheless, the study authors acknowledge that as the studies are based on observational data, a causal relationship cannot be co

Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, according to a study by Spanish...

Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs...

Breast cancer medications such as aromatase inhibitors, may lessen the effect of weight loss drugs, according to a study presented at...

A review paper has sought to clarify the relationship between obesity and breast cancer, and explore the potential role of bariatric...

Researchers have found that exosomes - small vesicles secreted by many cell types and released into blood or nearby tissues and fluids -...

Researchers from in the Department of Microbiology and Immunology and UofL Health, James Graham Brown Cancer Center at the University of...

Weight gain after breast cancer is a greater problem than previously thought, according to the first national survey on weight after...